Research and Markets (http://www.researchandmarkets.com/research/pjffs5/a_33country) has announced the addition of the "A 33-Country Survey of the Cancer Diagnostic Testing Market" report to their offering.
This new 33-country survey contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.
The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.
Geographic Coverage:
-
Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden,
Switzerland, UK, US
Over 200 Current and Emerging Cancer Diagnostic Tests:
- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines
-
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125,
Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen,
Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin,
Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific
Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal
Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor,
Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine
Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.
Contains 1,300 pages and 500 tables.
Companies Mentioned Include:
- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Elitech Group
- Enterix/Clinical Genomics
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
For more information visit http://www.researchandmarkets.com/research/pjffs5/a_33country
View source version on businesswire.com: http://www.businesswire.com/news/home/20160208005482/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics
